Alethia Biotherapeutics Inc.

Immunotherapeutics against disease-specific targets

Add To Watchlist
General Information
Company Name
Alethia Biotherapeutics Inc.
Founded Year
2002
Location (Offices)
Montreal, Canada +1
Founders / Decision Makers
Julie Laurin - Vice President, Drug Development Yves Cornellier - President and CEO Mario Filion - Co-Founder, Executive Vice President & Chief Scientific Officer
Number of Employees
12
Industries
Biotechnology, Health Care, Health and Wellness
Funding Stage
Debt Financing
Social Media

Alethia Biotherapeutics Inc. - Company Profile

Alethia BioTherapeutics is a Montreal-based biotechnology company founded in 2002. The company focuses on developing immunotherapeutics for disease-specific targets, operating within the Biotechnology and Health Care industries. In its most recent funding round in June 2019, Investissement Québec provided $4.00M in Debt Financing investment. Alethia's innovative approach to combatting diseases through immune system modulation has attracted significant support, positioning the company for potential growth and impact within the biotechnology landscape.

Taxonomy: Montreal, Monoclonal antibodies, Cancer therapeutics, Epithelial-to-mesenchymal transition, Ovarian cancer, Bone loss, G2 checkpoint inhibitor, sCLU glycoprotein, Prostate cancer, Bladder cancer, Kidney cancer, Breast cancer, Colon cancer, Lung cancer

Funding Rounds & Investors of Alethia Biotherapeutics Inc. (4)

View All
Funding Stage Amount No. Investors Investors Date
Debt Financing $4.00M 1
Investissement Québec, investor in Alethia Biotherapeutics Inc.'s Debt Financing round
06 Jun 2019
Series B $4.70M 4
GO Capital Fund, investor in Alethia Biotherapeutics Inc.'s Series B round
BDC Venture Capital, AgeChem Venture Fund +1 		02 Nov 2012
Series A $9.20M 4
GO Capital Fund, investor in Alethia Biotherapeutics Inc.'s Series A round
Epicenter Technologies, AgeChem Venture Fund +1 		07 Sep 2010
Seed Round $2.40M 1
GO Capital Fund, investor in Alethia Biotherapeutics Inc.'s Seed Round round
03 Apr 2008

Latest News of Alethia Biotherapeutics Inc.

View All

No recent news or press coverage available for Alethia Biotherapeutics Inc..

Similar Companies to Alethia Biotherapeutics Inc.

View All
Dana-Farber Cancer Institute - Similar company to Alethia Biotherapeutics Inc.
Dana-Farber Cancer Institute
Umoja Biopharma - Similar company to Alethia Biotherapeutics Inc.
Umoja Biopharma Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer by reengineering immune cells directly within the patient.
Carcidiag Biotechnologies - Similar company to Alethia Biotherapeutics Inc.
Carcidiag Biotechnologies French startup Carcidiag offers innovative cancer detection tool from Guéret, France.
Michiana Hematology Oncology (MHO) - Similar company to Alethia Biotherapeutics Inc.
Michiana Hematology Oncology (MHO) Bringing world-class cancer care to northern Indiana
Rutgers Cancer Institute - Similar company to Alethia Biotherapeutics Inc.
Rutgers Cancer Institute Rutgers Cancer Institute is committed to providing the most advanced, comprehensive, and compassionate cancer care.
Circle Decoration Circle Decoration

Want to dive deeper into Alethia Biotherapeutics Inc.? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now